Global Antibiotic Resistance Market by Disease, Pathogen, Drug Class (Oxazolidinone, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination therapies, others), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2018 to 2025

$4,700

Global antibiotic resistance market is expected to reach USD 8.21 Billion in 2017 to USD 13.16 Billion by 2025 at a CAGR of 6.20% from 2018 to 2025. Emergence of multidrug resistance pathogen and wide distribution of anti-MRSA drugs to combat the increasing resistance against antibiotic resistance along with a growing demand for generic drugs are primarily driving the market.

Market Overview:

Antibiotics are antimicrobial substance which is used to fight against the bacterial infection. They are also used to cure many conditions such as strep throat, sinus infections, urinary tract infections, ear infections, pneumonia, skin infections, and others. Antibiotics are classified on the basis of chemical structures, spectrum of activity and mode of action. The ability to resist the bacterial infection is termed as antibiotics resistance. It is a major concern worldwide. Major pharmaceutical companies on the forefront and involved in development of broad spectrum antibiotics. For instance, in 2018, Acurx Pharmaceuticals introduced ACX-362E, which is the US Food and Drug Administration (FDA) approved antibiotic candidate, designated as Qualified Infectious Disease Product (QIDP) with Clostridium difficile infection (CDI).

Report Description:

  • The base year for the study has been considered 2017, historic year 2015 and 2016 and, the forecast period considered is from 2018 to 2025. The antibiotic resistance market is analysed on the basis of value (USD Billion).
  • The study delivers a comprehensive analysis of global antibiotic resistance market by disease, pathogen, drug class and regions.
  • The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2018 to 2025.
  • Porter’s Five Forces model is used in order to recognize the competitive scenario in the global antibiotic resistance market. This report incorporates the industry analysis which is focused on providing an extensive view of the antibiotic resistance market.
  • The study also includes attractiveness analysis of disease, pathogen, drug class, and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
  • The report provides company profile of the key players operating in the antibiotic resistance market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
  • The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Market Dynamics:

Drivers:

  • Growing demand of generic drugs
  • High burden of antibiotic-resistant infections
  • Emergence of multi-drug resistant pathogens

Restraints:

  • Lack of Investment from major market players

Opportunities:

  • The policies for the development of new therapies for growing burden and severity of antibiotic-resistant infections

Challenges:

  • Increasing resistance against antibiotics associated with product recalls
  • Limited number of manufacturers in the field of antibiotic resistance.

Global Antibiotic Resistance Market Key Findings:

All the segments have been analysed on global, regional and country basis. The study includes the analysis of more than 30 countries for each segment.

Segmentation Analysis:

The antibiotic resistance market is segmented on the basis disease, pathogen and drug class.

  • The disease segment is classified into cUTI, cIAI, BSI, CDI, ABSSSI, HABP/VABP, and CABP. The cUTI segment is dominating the antibiotic resistance market with USD 1.06 Billion in 2017. Owing to treatment cost and limited treatment alternatives for Gram-negative pathogens, which account for majority of infection cases are major contributing factors for the growth of segment.
  • In pathogen segment ESBL-producing held the largest share in 2017 where as CDI, is anticipated to register the highest CAGR of 7.86% during the forecast period. These infections are difficult to be treated due to high resistance to current treatment alternatives. Therefore, impose a high cost burden as physicians are increasingly shifting towards novel antibiotics.
  • Drug class segment is divided into segments such as oxazolidinones, lipoglycopeptides, tetracyclines, cephalosporins, combination therapies, and others. Lipoglycopeptides dominated the segment with largest market share of 21.37% in 2017 due to high usage of these drugs. 

Regional Segmentation Analysis:

The regions analysed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. North America region dominated the global antibiotic resistance market with USD 2.62 Billion in 2017 where as Europe region held the second dominant position in the market.

  • North America region held the largest share due to launch of numerous drugs and the use of novel therapies are some of the factors that led to the growth of antibiotic resistance market in this region.
  • Europe is the second fastest growing region due to growing number of antibiotic-resistant infection contributing to increased antibiotic resistance in the region are creating opportunity for the growth of the market.

Global Antibiotic resistance Market Competitive Analysis:

Key players in the antibiotic resistance market are, Allergan, Melinta Therapeutics., Novartis AG, GlaxoSmithKline PLC, Merck & Co. Inc, Pfizer Inc, Novartis AG, Sanofi SA, Johnson & Johnson, Roche, Shionogi, Lupin and others. Novartis AG, Pfizer and Merck are the top leading players of the market. For instance, in 2018, Novartis entered into a licensing and equity agreement with Boston Pharmaceuticals to develop three novel anti-infective drug candidates against antibiotic-resistant Gram-negative infections.

*All our reports are customizable as per customer requirements

Scope

Key Points

Information

Evaluate Market Potential

Growth Rates (CAGR %)

Value (USD Billion) {Market Size}

USP of Report

Industry and Technology Trends

Market Evolution

Value Chain Analysis

Company Share Analysis

Competitive & Vendor landscape

SWOT Analysis of Each Company

Profit Margin Analysis

Analysis of More than 30 Countries for Each Segment

Base Year

2017

Historical Years

2015-2017

Forecast Period

2018-2025

Regional Analysis

North America, Europe, Asia Pacific, South America, and Middle East and Africa

Countries Analysis

U.S., Canada, Mexico, Germany, France, Sweden, Netherlands, U.K., Italy, Spain, Turkey, Switzerland, Belgium, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Brazil, Saudi Arabia, UAE, Egypt, Nigeria, South Africa

 

This study forecasts revenue and volume growth at global, regional, and country levels from 2015 to 2025. Fior Market Research has segmented the global antibiotic resistance market on the basis of below mentioned segments:

Global Antibiotic Resistance Market, By Disease:

  • Complicated Urinary Tract Infection (cUTI)
  • Complicated Intra-Abdominal Infections (cIAI)
  • Blood Stream Infections (BSI)
  • Clostridium difficile infections (CDI)
  • Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
  • Hospital Acquired Bacterial Pneumonia/Ventilator (HABP/VABP)         
  • Community Acquired Bacterial Pneumonia (CABP)

Global Antibiotic Resistance Market, By Pathogen:

  • Acinetobacter baumannii (Carbapenem-Resistant and ESBL-producing)
  • Pseudomonas aeruginosa (Carbapenem-Resistant)
  • Staphylococcus Aureus (Methicillin-Resistant)
  • E. coli/K. pneumoniae (Carbapenem-Resistant)
  • Streptococcus pneumoniae (Penicillin-Non-Susceptible)
  • Clostridium difficile (Cephalosporin-Resistant, Tetracycline-Resistant)
  • Enterococcus faecium (Vancomycin-Resistant)
  • Haemophilus Influenzae (Ampicillin-Resistant)

Global Antibiotic Resistance Market, By Drug Class:

  • Oxazolidinones
  • Lipoglycopeptides
  • Tetracyclines
  • Cephalosporins
  • Combination therapies
  • Others

Global Antibiotic Resistance Market, By Regions:

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Sweden
  • Netherlands
  • U.K.
  • Italy
  • Spain
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of Asia-Pacific
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Rest of South America
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of  Middle East and Africa
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
    4. Currency
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market attractiveness analysis by disease
      2. Market attractiveness analysis by pathogen
      3. Market attractiveness analysis by drug class
      4. Market attractiveness analysis by region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Growing Demand of Generic Drugs
      2. High Burden of Antibiotic-Resistant Infections
      3. Emergence of Multi-Drug Resistant Pathogens
    3. Restraints
      1. Lack of Investment from Major Market Players
    4. Opportunities
      1. The Policies for The Development of New Therapies for Growing Burden and Severity of Antibiotic-Resistant Infections
    5. Challenges
      1. Increasing Resistance Against Antibiotics Associated with Product Recalls
  6. Global Antibiotic Resistance  Market Analysis and Forecast, By Disease
    1. Segment Overview
    2. Complicated Urinary Tract Infection (cUTI)
    3. Blood Stream Infections (BSI)
    4. Clostridium difficile infections (CDI)
    5. Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
    6. Hospital Acquired Bacterial Pneumonia/Ventilator (HABP/VABP)
    7. Community Acquired Bacterial Pneumonia (CABP)
  7. Global Antibiotic Resistance  Market Analysis and Forecast, By Pathogen
    1. Segment Overview
    2. Acinetobacter baumannii
    3. Pseudomonas aeruginosa
    4. Staphylococcus Aureus
    5. E. coli/K. pneumonia
    6. Streptococcus pneumonia
    7. Clostridium difficile
    8. Enterococcus faecium
    9. Haemophilus Influenzae
  8. Global Antibiotic Resistance  Market Analysis and Forecast, By Drug Class
    1. Segment Overview
    2. Oxazolidinones
    3. Lipoglycopeptides
    4. Tetracyclines
    5. Cephalosporins
  9. Global Antibiotic Resistance  Market Analysis and Forecast, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. Sweden
      4. Netherlands
      5. U.K.
      6. Italy
      7. Spain
      8. Turkey
      9. Switzerland
      10. Belgium
      11. Rest of Europe
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
      4. South Korea
      5. Australia
      6. Singapore
      7. Malaysia
      8. Thailand
      9. Indonesia
      10. Philippines
      11. Rest of Asia-Pacific
    5. South America
      1. Brazil
      2. Argentina
      3. Colombia
      4. Rest of South America
    6. Middle East and Africa
      1. Saudi Arabia
      2. UAE
      3. Egypt
      4. Nigeria
      5. South Africa
      6. Rest of  Middle East and Africa
  10. Global Antibiotic Resistance  Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Antibiotic Resistance  Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Product Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. Pfizer Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2. Novartis AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3. Allergan
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4. Melinta Therapeutics
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5. Novartis AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6. GlaxoSmithKline PLC
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7. Merck & Co. Inc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Sanofi SA
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9. Johnson & Johnson
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10. Roche
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11. Shionogi
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12. Lupin
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13. Sun Pharma
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14. Teva
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Mylan
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Product Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  2. Global Complicated Urinary Tract Infection Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  3. Global Complicated Intra-Abdominal Infections Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  4. Global Blood Stream Infections Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  5. Global Clostridium difficile infections Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  6. Global Acute Bacterial Skin and Skin Structure Infections Antibiotic Resistance  Market, BY Region, 2015–2025 (USD Billion)
  7. Global Hospital Acquired Bacterial Pneumonia/Ventilator Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  8. Global Community Acquired Bacterial Pneumonia Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  9. Global Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  10. Global Acinetobacter baumannii Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  11. Global Pseudomonas aeruginosa Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  12. Global Staphylococcus Aureus Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  13. Global E. coli/K. pneumoniae Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  14. Global Streptococcus pneumoniae Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  15. Global Clostridium difficile Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  16. Global Enterococcus faecium Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  17. Global Haemophilus Influenzae Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  18. Global Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  19. Global Oxazolidinones Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  20. Global Lipoglycopeptides Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  21. Global Tetracyclines Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  22. Global Cephalosporins Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  23. Global Combination therapies Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  24. Global Others Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  25. Global Antibiotic Resistance  Market, By Region, 2015–2025 (USD Billion)
  26. Global Antibiotic Resistance  Market, By North America, 2015–2025 (USD Billion)
  27. North America Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  28. North America Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  29. North America Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  30. U.S. Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  31. U.S. Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  32. U.S. Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  33. Canada Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  34. Canada Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  35. Canada Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  36. Mexico Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  37. Mexico Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  38. Mexico Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  39. Europe Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  40. Europe Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  41. Europe Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  42. Germany Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  43. Germany Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  44. Germany Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  45. France Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  46. France Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  47. France Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  48. Sweden Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  49. Sweden Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  50. Sweden Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  51. Netherlands Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  52. Netherlands Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  53. Netherlands Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  54. U.K. Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  55. U.K. Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  56. U.K. Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  57. Italy Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  58. Italy Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  59. Italy Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  60. Spain Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  61. Spain Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  62. Spain Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  63. Turkey Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  64. Turkey Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  65. Turkey Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  66. Switzerland Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  67. Switzerland Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  68. Switzerland Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  69. Belgium Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  70. Belgium Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  71. Belgium Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  72. Asia Pacific Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  73. Asia Pacific Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  74. Asia Pacific Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  75. Japan Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  76. Japan Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  77. Japan Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  78. China Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  79. China Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  80. China Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  81. India Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  82. India Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  83. India Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  84. South Korea Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  85. South Korea Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  86. South Korea Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  87. Australia Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  88. Australia Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  89. Australia Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  90. Singapore Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  91. Singapore Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  92. Singapore Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  93. Malaysia Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  94. Malaysia Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  95. Malaysia Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  96. Thailand Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  97. Thailand Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  98. Thailand Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  99. Indonesia Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  100. Indonesia Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  101. Indonesia Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  102. Philippines Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  103. Philippines Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  104. Philippines Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  105. South America Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  106. South America Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  107. South America Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  108. Brazil Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  109. Brazil Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  110. Brazil Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  111. Argentina Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  112. Argentina Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  113. Argentina Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  114. Colombia Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  115. Colombia Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  116. Colombia Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  117. Middle East and Africa Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  118. Middle East and Africa Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  119. Middle East and Africa Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  120. Saudi Arabia Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  121. Saudi Arabia Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  122. Saudi Arabia Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  123. UAE Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  124. UAE Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  125. UAE Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  126. Egypt Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  127. Egypt Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  128. Egypt Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  129. Nigeria Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  130. Nigeria Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  131. Nigeria Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)
  132. South Africa Antibiotic Resistance  Market, By Disease, 2015–2025 (USD Billion)
  133. South Africa Antibiotic Resistance  Market, By Pathogen, 2015–2025 (USD Billion)
  134. South Africa Antibiotic Resistance  Market, By Drug Class, 2015–2025 (USD Billion)

 

List of Figures 

  1. Global Antibiotic Resistance  Market Segmentation
  2. Antibiotic Resistance  Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-Down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Global Antibiotic Resistance  Market attractiveness analysis by Disease
  9. Global Antibiotic Resistance  Market attractiveness analysis by Pathogen
  10. Global Antibiotic Resistance  Market attractiveness analysis by Drug Class
  11. Global Antibiotic Resistance  Market attractiveness analysis by Region
  12. Global Antibiotic Resistance  Machine Market: Dynamics
  13. Global Antibiotic Resistance  Market Share by Diseases (2017 & 2025)
  14. Global Antibiotic Resistance  Market Share by Pathogens (2017 & 2025)
  15. Global Antibiotic Resistance  Market Share by Drug Class (2017 & 2025)
  16. Global Antibiotic Resistance  Market Share by Regions (2017 & 2025)
  17. Global Antibiotic Resistance  Market Share by Company (2018)

1

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

  • Market research helps businesses strengthen a company’s position
  • Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
  • Market research helps in identifying the potential threats and opportunities associated with the business industry
  • Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

  • Data Collection
  • Data Synthesis
  • Market Deduction & Formulation
  • Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

  • Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
  • Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends. 
  • Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information. 
    • We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:
      • Export & Import Data
      • Business Information related to trade and its statistics
      • Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.
  • In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
  • Examining demographic along with psychographic segmentation for market evaluation
  • Analyzing the macro and micro-economic indicators for each demography
  • Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

  • Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
  • Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology. 
    • Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.
    • The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample


Our Clients

Some Facts about Fior Markets

1%

Free Customization

1+

Countries can be added on demand

1

Free yearly update on purchase of Multi/Corporate User License

1+

Companies served till date

Customized Research Programme
Premium Customer Service

We serve our customers 24x7 for 365 days through calls, emails and live chat options.

Syndicated market research
Exceptional Market Report

Huge database of exceptional market reports bringing market intelligence to your fingertips.

Domain Specific Analytics
Secured Payment Options

SSL enabled, we offer you various secured payment options for risk free purchase.